ARTV
NASDAQ · Biotechnology
Artiva Biotherapeutics Inc
$4.01
+0.05 (+1.26%)
Analyst Consensus
Strong Buy
12
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+103.0% upside
Low Target
$7.28
Average Target
$8.14
High Target
$10.62
Current Price
$4.01
Current
$4.01
$4.01
Target
$8.14
$8.14
$7.28
$8.14 avg
$10.62
Scenario Analysis
Bear Case
$7.28
81.5%
Low target
Base Case
$8.14
+103.0%
Avg target
Bull Case
$10.62
+164.8%
High target
Risk/Reward
2.0x
Favorable
Price in Context
52-Week High
$14.53
-72.4% from high
52-Week Low
$2.96
+35.5% from low
Target vs 52W High
$8.14
-44.0% vs high
Next Earnings Report
Nov 18, 2026
1d
tomorrow
EPS Est: $-0.56
Earnings in 1 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 38 | 82% | $257.58 | -12.7% |
| AMGN | Hold | 42 | 43% | $190.87 | -59.3% |
| GILD | Strong Buy | 36 | 83% | $362.68 | +115.8% |
| VRTX | Strong Buy | 39 | 82% | $438.34 | -19.3% |
| REGN | Buy | 36 | 72% | $76.80 | -92.0% |
| MRNA | Hold | 31 | 32% | $149.45 | -31.8% |
| NTRA | Strong Buy | 31 | 90% | $142.91 | -51.4% |
| RVMD | Strong Buy | 31 | 94% | $114.11 | -32.5% |